USPTO 2015–2025 USPTO PatentsView US Corporation

Pop Test Oncology Llc

USPTO PatentsView assignee record - 19 granted patents across 14 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

8.1

Avg claims per patent

-54%

5-year filing velocity

The verdict

Pop holds 19 US patents across 14 technology areas, rank #15,547 of 50,000 tracked assignees.

#15,547
of 50,000 US assignees by volume: Top 56%
by Innovation Score (33.4/100): 8.1
avg claims per patent: -54%
filing velocity, last 5 yrs

Portfolio overview

Pop Test Oncology Llc has been granted 19 US utility patents between 2015 and 2025, placing Pop Test Oncology Llc at rank #15,547 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Pop Test Oncology Llc is one of the more focused assignees in the PatentsView dataset. By volume, Pop sits between Perfect Sense, Inc. (19 patents, rank #15,543) and Proampac Holdings Inc. (19 patents, rank #15,551) - the closest US assignees by grant volume. The composite Innovation Score of 33.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 13 in the 2015–2019 window, a -54% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Pop Test Oncology Llc's 8.1 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Pop Test Oncology Llc against peers pursuing similar technology classes.

Perfect Sense

19
Pfenex

19
Pipeline Medical

19
Polyic & KG

19
Postle Industries

19
Precision

19
Privowny

19
Proampac Holdings

19
Pop Test Oncology ◀

19

What this shows Pop holds 19 patents at rank #15,547, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pop

By rank, the assignees closest to #15,547 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Pop's primary technology class.

Pop's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

33 Top 56% higher than 44% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Pop Test Oncology Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.3%
2016	3	15.8%
2017	3	15.8%
2018	3	15.8%
2019	3	15.8%
2020	1	5.3%
2022	1	5.3%
2023	2	10.5%
2025	2	10.5%

Which technologies does Pop Test Oncology Llc patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 18

C07J - STEROIDS 18

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 11

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 11

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 9

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 8

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 7

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 1

C07D - HETEROCYCLIC COMPOUNDS 1

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 1

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

Top 14 of 14 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Simple

Velocity Declining

Where it ranks

Overall rank by patents

#15,547

Across all tracked assignees

Innovation Score

33.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Pop Test Oncology Llc hold?

Pop Test Oncology Llc holds 19 US granted patents filed between 2015 and 2025, spanning 14 technology areas.

What is Pop Test Oncology Llc's Innovation Score?

Pop Test Oncology Llc has an Innovation Score of 33.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Pop Test Oncology Llc focus on?

Pop Test Oncology Llc's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 18 patents. The company has filed patents in 14 CPC subclasses total.

Is Pop Test Oncology Llc's patent filing rate increasing or decreasing?

Pop Test Oncology Llc's recent filing velocity is -54% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Pop Test Oncology Llc's patents?

Pop Test Oncology Llc's patents average 8.1 claims each. This is relatively simple claim structure, typical for focused inventions.

How is the Pop Test Oncology Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Pop's 19 grants land it in the top 56% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Pop ranks #15,547 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.